Cancer cells impair monocyte-mediated T-cell activation by disrupting inflammatory pathways in the tumor microenvironment.

The immune system plays a pivotal role in colorectal cancer (CRC), with immune cells such as T cells, natural killer (NK) cells, macrophages, and dendritic ...

Nutrition encompasses a crucial influence on health and diseases, notably within the domain of cancer, where it intersects ...

The discovery improves the scientific understanding of cancer progression and anticancer immunity, and could yield new clinical tools for assessing and reducing metastasis risk. Specially packaged ...

A new publication from Genes & Diseases; DOI  10.1016/j.gendis.2024.101441, discusses how Ce6-GFFY is a novel photosensitizer ...

Finally, implication of the cGAS pathway in regulating tumor immunity may provide an additional biomarker for response assessment to mIDH inhibitors in patients with glioma and other cancers.

In part 3 of our interview with hematologist-oncologist Don M. Benson, MD, PhD, The Ohio State University Comprehensive ...

B7H3 is a pan-cancer antigen considered a promising target for immunotherapy. However, targeting B7H3 using bispecific T-cell engagers (BiTEs) presents the problem of systemic toxicity.

Survival Rate and 37% Reduction in Risk of Death Multiple Patients with Complete Responses (CRs) and/or Partial Response (PR) ...